Encompass Health Corporation $EHC Shares Sold by State of Alaska Department of Revenue

State of Alaska Department of Revenue lessened its position in Encompass Health Corporation (NYSE:EHC) by 3.8% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,511 shares of the company’s stock after selling 495 shares during the period. State of Alaska Department of Revenue’s holdings in Encompass Health were worth $1,534,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of EHC. Congress Asset Management Co. acquired a new stake in shares of Encompass Health in the 2nd quarter worth approximately $92,691,000. Dakota Wealth Management acquired a new stake in Encompass Health in the second quarter worth approximately $317,000. Retirement Guys Formula LLC bought a new position in Encompass Health during the 2nd quarter valued at $207,000. TD Private Client Wealth LLC increased its position in shares of Encompass Health by 165.1% during the 2nd quarter. TD Private Client Wealth LLC now owns 8,125 shares of the company’s stock valued at $996,000 after purchasing an additional 5,060 shares during the period. Finally, Public Employees Retirement System of Ohio increased its position in shares of Encompass Health by 1.4% during the 2nd quarter. Public Employees Retirement System of Ohio now owns 33,263 shares of the company’s stock valued at $4,079,000 after purchasing an additional 459 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently weighed in on EHC shares. Truist Financial raised their target price on Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a research note on Thursday, August 14th. KeyCorp upped their price target on shares of Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a report on Tuesday, September 16th. Wall Street Zen lowered shares of Encompass Health from a “strong-buy” rating to a “buy” rating in a research report on Friday, June 6th. Bank of America boosted their target price on shares of Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. Finally, UBS Group raised their target price on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Thursday. One research analyst has rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $139.86.

Encompass Health Price Performance

NYSE EHC opened at $123.13 on Friday. The company has a 50 day simple moving average of $121.25 and a 200-day simple moving average of $115.55. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. The firm has a market capitalization of $12.40 billion, a price-to-earnings ratio of 24.10, a price-to-earnings-growth ratio of 2.16 and a beta of 0.93. Encompass Health Corporation has a 52-week low of $87.85 and a 52-week high of $127.86.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Monday, August 4th. The company reported $1.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.20 by $0.20. The business had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The firm’s revenue was up 12.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.11 earnings per share. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Equities research analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. This is a positive change from Encompass Health’s previous quarterly dividend of $0.17. The ex-dividend date of this dividend is Wednesday, October 1st. Encompass Health’s payout ratio is currently 14.87%.

Insider Activity

In other news, EVP Patrick William Tuer sold 1,020 shares of the stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the sale, the executive vice president directly owned 18,846 shares of the company’s stock, valued at $2,329,177.14. This represents a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.00% of the stock is owned by company insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.